A collaborative research effort between UNIST and the Korea Institute of Science and Technology (KIST) has led to the ...

Rallybio’s lead program has crashed out. Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212 ...

It would be highly unusual, and perhaps illegal, the people said, to use tax data to enact criminal penalties. IRS executives told Homeland Security officials that their request probably violates ...

and preclinical data on DT-7012, a Treg depleting anti-CCR8 antibody Preclinical findings highlight immuno-oncology breakthrough properties for its PAR2 biased negative allosteric modulator program ...